Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01
Published November 13, 2024 · Recall initiated: October 30, 2024
Summary
FDA records drug Class II recall D-0039-2025, published November 13, 2024 and initiated October 30, 2024. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 60,594 units; Lot: Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Missing Label
What to do
Voluntary: Firm initiated · Letter
Get an email if REGADENOSON has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- REGADENOSON
- Manufacturer
- Baxter Healthcare Corporation
- Distributor
- Nationwide within the USA
- UPC
- 0336000364010
- Lot
- Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India,November 13, 2024
- FDAAscorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals,November 13, 2024
- FDAMorphine Sulfate Extended-Release Tablets 30 mg, 100-count bottles, Rx Only, Manufactured by Mayne Pharma,November 13, 2024
- FDAIbuprofen 800mg, Generic for: Motrin, Each tablet contains: Ibuprofen, USP 800 mg, Packaged and DistributedNovember 13, 2024
- FDAMorphine Sulfate Extended-Release Tablets 15 mg, 100-count per bottle, Rx Only, Manufactured by Mayne Pharma,November 13, 2024
- FDABulk Mexican sweet bread varieties including conchas, fino ellotes, fino curenos, danes ellotes, danesNovember 13, 2024
Questions about this recall
Was Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01 recalled?
Yes. FDA published recall D-0039-2025 on November 13, 2024. Reported hazard: Labeling: Missing Label
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: REGADENOSON. UPC: 0336000364010.